EU-Japan Biotech & Pharma Partnering Conference 2026

16 Sept – 5 Oct 2026 | Osaka, Japan

HomeAgenda
Register
Register
Register

Belgian Red Cross

Company (large) /大企業

www.lysantum.com/Mechelen, Belgium
15 profile visits

About

The Belgian Red Cross is a leading independent humanitarian organisation in Belgium and a member of the International Red Cross and Red Crescent Movement, founded in 1864.. Building on its long-standing expertise in blood processing, Belgian Red Cross has developed Lysantum®, a patented human platelet lysate (HPL) produced from surplus donor platelets as a xeno-free alternative to Fetal Bovine Serum (FBS). Manufactured under GMP-aligned conditions with full European traceability, Lysantum delivers high consistency, safety, and scalability. Its fibrinogen-depleted, pathogen-inactivated formulation supports robust and reproducible cell expansion across a wide range of cell types. With reliable supply and growth kinetics up to twice as fast as FBS, it enables more efficient and cost-effective development.

Social media

Disease Area / 疾患領域

Oncology / がんNeurology & Psychiatry / 中枢神経、精神疾患Immunology / 免疫・炎症Metabolic diseases / 代謝Musculoskeletal System / 筋骨格系Dermatology and sensory system / 皮膚・感覚器Rare diseases / 希少疾患Others / その他

Business Type / 業種

Reagents / 試薬提供

Modalities / モダリティ

Cell therapy /細胞治療

Business Domain / 分野

Others /その他

Technologies / 技術

Cell cultivation system and 3D-bioprinter / 細胞培養装置、3Dバイオプリンター

Additional Information

Researched company/organisation type / マッチングご希望企業・機関のタイプ

Companies and Academia etc. (Joint research and development purpose) / 企業やアカデミア等(共同での研究、開発を目的)Major pharma etc. (Out-licensing purpose) / 大手ファーマ等(アウトライセンスを目的)Startups, BioTech etc. (In-licensing or Partnership/Collaboration purpose) / 独自の技術やシーズを持つスタートアップ、バイオテック企業等(インライセンス、共同研究などを目的)Companies and Entities (Providing your services or technology to your clients) / 技術・サービス(研究、開発、製造等の提供を目的)CROs, CMOs, CDMOs, etc. (Partnerships)/CRO、CMO、CDMO等(インライセンス、共同研究などを目的)Consultants, Agents, etc. (Supporting overseas business development) /コンサルタント、代理店等(海外での事業展開支援などを目的)

Researched disease area / マッチングご希望の疾患領域

Oncology / がんNeurology & Psychiatryy / 中枢神経、精神疾患Immunology / 免疫・炎症Metabolic diseases / 代謝Musculoskeletal System / 筋骨格系Gastroenterology / 消化器Dermatology and sensory system / 皮膚・感覚器Rare diseases / 希少疾患

Researched Modality / マッチングご希望のモダリティ

Cell therapy / 細胞治療Vaccine / ワクチン

Researched Technologies / マッチングご希望の技術

Cell cultivation system and 3D-bioprinter/ 細胞培養装置、3Dプリンター

Marketplace (1)

  • Product

    Lysantum Human Platelet Lysate

    Lysantum: GMP-grade, xeno-free human platelet lysate (HPL) from Belgian Red Cross, replacing FBS in cell therapy & regenerative medicine. Research & Clinical grades. Only blood establishment to both manufacture and commercialize HPL—full traceability

    • Importer
    • Distribution Partner
    • Biotech and Lifescience